Literature DB >> 16409460

Co-localization of von Willebrand factor with platelet thrombi, tissue factor and platelets with fibrin, and consistent presence of inflammatory cells in coronary thrombi obtained by an aspiration device from patients with acute myocardial infarction.

Y Hoshiba1, K Hatakeyama, T Tanabe, Y Asada, S Goto.   

Abstract

BACKGROUND: Detailed histochemical analysis of coronary thrombi obtained freshly from acute phase of myocardial infarction patients may provide information necessary to understand the mechanism of coronary occlusive thrombus formation. METHODS AND
RESULTS: Coronary thrombi causing myocardial infarction were obtained from 10 consecutive patients of myocardial infarction in the acute phase, using a newly developed aspiration catheter. All the fixed specimens of coronary thrombi, by hematoxylin and eosin staining, were found to contain three major constituents, namely, platelets, densely packed fibrin and inflammatory cells, including polymorphonuclear and mononuclear cells, although their distribution in each specimen is totally heterogeneous. Immunohistochemical staining revealed the prominent presence of von Willebrand factor (VWF) at the sites of platelet accumulation, presence of tissue factor and platelets at the sites of deposition of fibrin fibrils. It also revealed the presence of CD16-, CD45- and CD34-positive cells, yet the functional roles of these cells have still to be elucidated. There are weak positive correlation between the number of inflammatory cells involved in the unit area of coronary thrombi specimen and the time of collection of the specimens after the onset of chest pain.
CONCLUSIONS: In spite of various limitations, our results contain information suggesting the possible role of VWF in platelet-thrombus formation, possible important role played by tissue factor and activated platelets in the formation of fibrin fibrils, and the positive relationship between inflammatory cells migration and the formation of occlusive thrombi in human coronary arteries.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16409460     DOI: 10.1111/j.1538-7836.2005.01701.x

Source DB:  PubMed          Journal:  J Thromb Haemost        ISSN: 1538-7836            Impact factor:   5.824


  13 in total

Review 1.  Optimizing the use of thrombolytics in ST-segment elevation myocardial infarction.

Authors:  Michael A Morse; Josh W Todd; George A Stouffer
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

2.  Increased serum levels of interleukin-6 and von Willenbrand Factor in early phase of acute coronary syndrome in a young and multiethnic Malaysian population.

Authors:  Wen Ni Tiong; Alan Yean Yip Fong; Edmund Ui Hang Sim; Hiang Chuan Chan; Tiong Kiam Ong; Boon Cheng Chang; Kui Hian Sim
Journal:  Heart Asia       Date:  2012-10-16

3.  Insights into the composition of stroke thrombi: heterogeneity and distinct clot areas impact treatment.

Authors:  Rui-Gang Xu; Robert A S Ariëns
Journal:  Haematologica       Date:  2020-01-31       Impact factor: 9.941

4.  Acute myocardial infarction as a systemic prothrombotic condition evidenced by increased von Willebrand factor protein over ADAMTS13 activity in coronary and systemic circulation.

Authors:  Manabu Horii; Shiro Uemura; Masahito Uemura; Masanori Matsumoto; Hiromichi Ishizashi; Keiichi Imagawa; Hajime Iwama; Yukiji Takeda; Hiroyuki Kawata; Tamio Nakajima; Yoshihiro Fujimura; Yoshihiko Saito
Journal:  Heart Vessels       Date:  2008-09-20       Impact factor: 2.037

5.  Fibrin architecture in clots: a quantitative polarized light microscopy analysis.

Authors:  Peter Whittaker; Karin Przyklenk
Journal:  Blood Cells Mol Dis       Date:  2008-12-02       Impact factor: 3.039

6.  Double-blind, placebo-controlled Phase II studies of the protease-activated receptor 1 antagonist E5555 (atopaxar) in Japanese patients with acute coronary syndrome or high-risk coronary artery disease.

Authors:  Shinya Goto; Hisao Ogawa; Masaru Takeuchi; Marcus D Flather; Deepak L Bhatt
Journal:  Eur Heart J       Date:  2010-08-30       Impact factor: 29.983

7.  Protective anti-inflammatory effect of ADAMTS13 on myocardial ischemia/reperfusion injury in mice.

Authors:  Simon F De Meyer; Alexander S Savchenko; Michael S Haas; Daphne Schatzberg; Michael C Carroll; Alexandra Schiviz; Barbara Dietrich; Hanspeter Rottensteiner; Friedrich Scheiflinger; Denisa D Wagner
Journal:  Blood       Date:  2012-08-22       Impact factor: 22.113

Review 8.  The TIMI Study Group's Contributions to the Advancement of Cardiology -With Focus on Atherosclerotic Cardiovascular Disease.

Authors:  Eri Toda Kato; Shinya Goto
Journal:  J Atheroscler Thromb       Date:  2021-04-13       Impact factor: 4.928

9.  Aspirin at 120: Retiring, recombining, or repurposing?

Authors:  Carlo Patrono; Bianca Rocca
Journal:  Res Pract Thromb Haemost       Date:  2021-05-28

10.  Cellularity and structure of fresh human coronary thrombectomy specimens; presence of cells with markers of progenitor cells.

Authors:  Ion S Jovin; Li Lei; Yan Huang; Zhengrong Hao; Jeptha P Curtis; Joseph J Brennan; Michael S Remetz; John F Setaro; Steven E Pfau; Christopher J Howes; Jude F Clancy; Henry S Cabin; Michael W Cleman; Frank J Giordano
Journal:  J Cell Mol Med       Date:  2012-12       Impact factor: 5.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.